Buscar resultados de ensayos clínicos
Pyoderma - 36 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2014-12-08 Intervenciones: Drug: gevokizumab |
Terminated |
Nombre del estudio: An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2014-12-22 Intervenciones:
|
Completed |
Nombre del estudio: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2013-06-17 Intervenciones: Drug: gevokizumab |
Completed |
Nombre del estudio: Canakinumab for Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2011-02-17 Intervenciones: Drug: Canakinumab Monoclonal antibody inhibiting interleukin 1 beta |
Recruiting |
Nombre del estudio: An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2017-04-27 Intervenciones: Biological: Ixekizumab Injection Other Name: Taltz |
Withdrawn |
Nombre del estudio: Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2008-08-04 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2017-02-17 Intervenciones: Drug: APD334 Other Name: Etrasimod |
Recruiting |
Nombre del estudio: Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2016-03-28 Intervenciones: Drug: Secukinumab |
Withdrawn |
Nombre del estudio: Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum Condición: Pyoderma Gangrenosum Fecha: 2008-06-02 Intervenciones: Drug: adalimumab 40 mg weekly adalimumab injection. |
Completed |
Nombre del estudio: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease Condición:
|